Point-of-care platelet function testing offers a rapid method to assess antiplatelet response during endovascular procedures, though variability between assays and uncertain clinical outcome prediction remain challenges.
Point-of-care testing should not guide antiplatelet adjustments; leaves open need for standardized, outcome-validated assays in endovascular care.
Antiplatelet agents are an important component of the preventive strategies currently used in clinical practice to minimize the risk of thromboembolic events during and after endovascular procedures. Because of the variability in the response to antiplatelet agents, measuring the degree of platelet inhibition may help identify and properly treat poor responders. POC testing is defined as diagnostic testing at or near the site of patient care. Knowledge of the specifics of these devices among practicing neurointerventionalists is relatively limited. In this article, the different POC devices available are presented, and their clinical utility in relation to endovascular procedures is discussed.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: